This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Jan;11(1):37-9.

doi: 10.1007/s11908-009-0006-6.

Japanese encephalitis: new vaccines

PMID: 19094823
DOI: 10.1007/s11908-009-0006-6

Comment

Japanese encephalitis: new vaccines

Mary E Wilson. Curr Infect Dis Rep. 2009 Jan.

. 2009 Jan;11(1):37-9.

doi: 10.1007/s11908-009-0006-6.

Author

PMID: 19094823
DOI: 10.1007/s11908-009-0006-6

No abstract available

PubMed Disclaimer

Comment on

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial.
Tauber E, Kollaritsch H, Korinek M, Rendi-Wagner P, Jilma B, Firbas C, Schranz S, Jong E, Klingler A, Dewasthaly S, Klade CS. Tauber E, et al. Lancet. 2007 Dec 1;370(9602):1847-53. doi: 10.1016/S0140-6736(07)61780-2. Lancet. 2007. PMID: 18061060 Clinical Trial.

References

1. N Engl J Med. 2004 Jul 22;351(4):370-8 - PubMed
1. Vaccine. 2007 Apr 30;25(17):3445-53 - PubMed
1. Lancet. 2003 Mar 8;361(9360):821-6 - PubMed
1. Lancet. 2007 Dec 1;370(9602):1806-8 - PubMed
1. Lancet Neurol. 2008 Feb;7(2):116-8 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.